HANGZHOU TIGERMED CONSULTING CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 49.64 CNY | -4.04% |
|
-10.85% | -9.70% |
| Mar. 29 | Tigermed Consulting's Profit, Revenue Climb in 2023 | MT |
| Mar. 28 | Hangzhou Tigermed Consulting Co., Ltd Announces Final Dividend for the Year Ended December 31, 2023, Payable on 31 July 2024 | CI |
Chart calendar Hangzhou Tigermed Consulting Co., Ltd
7e0c5f6e1a64b6e01a5ed5.tfDNEWtcFzTWMvi-CYjvHbgVAGzUgfYds7EwynlADek.8pGlIggLXVCmYqnseriZeIwtbDyewLhK5MZj8yANXIrMgqlmIglxcbB_wA~05071ea947a7bc91a7a24c61adae044b
Upcoming events on Hangzhou Tigermed Consulting Co., Ltd
Past events on Hangzhou Tigermed Consulting Co., Ltd
| 2024-03-28 07:10 am | Q4 2023 Earnings Release |
| 2024-03-21 03:00 am | Extraordinary Shareholders Meeting |
| 2023-10-27 | Q3 2023 Earnings Release |
| 2023-08-25 06:39 am | Q2 2023 Earnings Release |
| 2023-05-22 10:00 pm | Annual General Meeting |
| 2023-04-24 | Q1 2023 Earnings Release |
| 2023-03-28 | Q4 2022 Earnings Release |
| 2022-11-23 02:00 am | Extraordinary Shareholders Meeting |
| 2022-10-24 | Q3 2022 Earnings Release |
| 2022-08-25 07:05 am | Interim 2022 Earnings Release |
| 2022-05-19 10:00 pm | Annual General Meeting |
| 2022-04-25 | Q1 2022 Earnings Release |
| 2022-03-28 07:22 am | FY 2021 Earnings Release |
| 2021-10-21 | Q3 2021 Earnings Release |
| 2021-10-15 03:00 am | Extraordinary Shareholders Meeting |
| 2021-09-26 | Extraordinary Shareholders Meeting |
| 2021-08-24 | Interim 2021 Earnings Call |
| 2021-08-24 | Interim 2021 Earnings Release |
| 2021-08-08 10:00 pm | Extraordinary Shareholders Meeting |
| 2021-05-20 10:00 pm | Annual General Meeting |
Past dividends on Hangzhou Tigermed Consulting Co., Ltd
| 2023-07-06 | Annual 0.55 CNY |
| 2022-05-30 | Annual 0.5 CNY |
| 2021-05-31 | Annual 0.3 CNY |
| 2020-05-21 | Annual 0.278 CNY |
| 2019-06-30 | Annual 0.35 CNY |
| 2018-05-29 | Final Payment 0.2 CNY |
| 2017-09-18 | Interim Payment 0.1 CNY |
| 2016-05-19 | Annual 0.1 CNY |
| 2015-05-19 | Annual 0.2 CNY |
| 2014-04-21 | Annual 0.4 CNY |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 2 803 2 966 -5.49% | 3 192 3 231 -1.19% | 5 214 4 526 15.2% | 7 085 7 133 -0.67% | 7 384 7 820 -5.57% | 8 462 |
|
EBITDA Million CNY | Released Forecast Spread | 1 132 927 22.15% | 2 308 1 037 122.57% | 3 820 1 348 183.36% | 2 963 3 324 -10.86% | 2 949 2 854 3.33% | 2 387 |
|
EBIT Million CNY | Released Forecast Spread | 1 085 886 22.46% | 2 222 913 143.36% | 3 697 3 009 22.85% | 2 678 2 014 32.95% | 2 610 3 065 -14.85% | 2 798 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 1 089 965 12.84% | 2 219 1 989 11.57% | 3 690 2 857 29.12% | 2 595 3 039 -14.62% | 2 490 2 992 -16.77% | 2 718 |
|
Net income Million CNY | Released Forecast Spread | 842 733 14.88% | 1 750 1 631 7.29% | 2 879 2 259 27.44% | 2 016 2 394 -15.78% | 2 027 2 358 -14.07% | 2 156 |
|
EPS CNY | Released Forecast Spread | 1,13 0,98 15.54% | 2,19 1,92 14.32% | 3,30 2,59 27.48% | 2,33 2,79 -16.58% | 2,34 2,70 -13.23% | 2,48 |
| Announcement Date | 28/02/20 | 29/03/21 | 10/03/22 | 28/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 1 819 1 181 53.97% | 1 818 699 160.18% | 1 776 1 376 29.09% | 3 594 2 982 20.53% | 1 812 1 755 3.26% | 1 679 1 549 8.42% | 1 805 1 859 -2.95% | 1 906 2 261 -15.68% | 3 711 3 879 -4.33% | 1 940 1 965 -1.29% | 1 734 2 012 -13.82% | 2 216 | 2 165 | 2 209 | 2 047 |
|
EBIT Million CNY | Released Forecast Spread | 1 356 285 376.57% | 654 189 245.77% | 827 338 144.36% | 906 746 21.5% | 520 509 2.18% | 581 667 -12.77% | 418 462 -9.46% | 481 567 -15.25% | 1 599 950 68.27% | 713 700 1.83% | 404 | ||||
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 1 349 551 144.79% | 656 843 -22.15% | 824 705 16.89% | 1 480 1 223 21% | 526 933 -43.6% | 589 1 026 -42.58% | 631 676 -6.66% | 968 787 23% | 1 599 1 310 22.07% | 715 839 -14.78% | 176 464 -62.11% | ||||
|
Net income Million CNY | Released Forecast Spread | 1 093 446 145.3% | 518 687 -24.54% | 674 580 16.23% | 1 192 990 20.4% | 413 758 -45.59% | 411 862 -52.28% | 568 551 3.12% | 820 616 33.04% | 1 388 1 090 27.37% | 491 735 -33.19% | 147 451 -67.44% | ||||
|
EPS CNY | Released Forecast Spread | 1,26 0,45 181.93% | 0,60 0,63 -4.13% | 0,78 0,64 21.4% | 0,48 0,66 -27.61% | 0,47 0,62 -24.12% | 0,66 0,61 7.5% | 0,95 0,51 88.12% | 0,56 0,71 -21.6% | 0,17 0,46 -62.97% | 0,68 | 0,82 | 0,80 | 0,32 | ||
| Announcement Date | 10/03/22 | 26/04/22 | 25/08/22 | 25/08/22 | 25/10/22 | 28/03/23 | 25/04/23 | 25/08/23 | 25/08/23 | 27/10/23 | 28/03/24 | - | - | - | - |
More events
Past sector events for Hangzhou Tigermed Consulting Co., Ltd
| 2024-04-17 | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
| 2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 300347 Stock
- Calendar Hangzhou Tigermed Consulting Co., Ltd
